Multiple endocrine neoplasia type 2B
MONDO:0008082An autosomal dominant disorder caused by specific pathogenic variants in the RET gene, characterized by an increased risk of very early onset medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism, and mucosal neuromas.
Also known as: MEN2B, RET-related multiple endocrine neoplasia type 2B, Wagenmann-Froboese syndrome, men 2B, men IIB, men type 2B, men type IIB, multiple endocrine adenomatosis type IIB
2793 clinical trials for this condition and its sub-types, 2 tagged with Multiple endocrine neoplasia type 2B itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Researchers track rare thyroid cancer to uncover its secrets
Knowledge-focused OngoingThis study follows children and adults with medullary thyroid cancer (MTC), often linked to a genetic condition called MEN2. Researchers will track how the cancer grows and affects health over time using regular check-ups, blood tests, and imaging. No treatment is given, but part…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC